Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"

Author(s): Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al.

Abstract

New diagnostic criteria for multiple sclerosis integrating magnetic resonance image assessment with clinical and other paraclinical methods were introduced in 2001. The "McDonald Criteria" have been extensively assessed and used since 2001. New evidence and consensus now strengthen the role of these criteria in the multiple sclerosis diagnostic workup to demonstrate dissemination of lesions in time, to clarify the use of spinal cord lesions, and to simplify diagnosis of primary progressive disease. The 2005 Revisions to the McDonald Diagnostic Criteria for MS should simplify and speed diagnosis, whereas maintaining adequate sensitivity and specificity.

Similar Articles

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study

Author(s): Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, et al.

Axonal transection in the lesions of multiple sclerosis

Author(s): Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, et al.

Magnetic resonance frequency shifts during acute MS lesion formation

Author(s): Wiggermann V, Hernández Torres E, Vavasour IM, Moore GR, Laule C, et al.

Weekly diffusion-weighted imaging of normal-appearing white matter in MS

Author(s): Rocca MA, Cercignani M, Iannucci G, Comi G, Filippi M

Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

Author(s): van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, et al.

MRI in multiple sclerosis: current status and future prospects

Author(s): Bakshi R, Thompson AJ, Rocca MA, Pelletier D, Dousset V, et al.

Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T

Author(s): Ingrisch M, Sourbron S, Morhard D, Ertl-Wagner B, Kümpfel T, et al.

Diffusion tensor magnetic resonance imaging in multiple sclerosis

Author(s): Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G

Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis

Author(s): Narayana PA, Zhou Y, Hasan KM, Datta S, Sun X, et al.

White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis

Author(s): Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, et al.

Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis

Author(s): Radü EW, Bendfeldt K, Mueller-Lenke N, Magon S, Sprenger T

Clinical correlations of brain lesion distribution in multiple sclerosis

Author(s): Vellinga MM, Geurts JJ, Rostrup E, Uitdehaag BM, Polman CH, et al.

Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR

Author(s): van Waesberghe JH, van Walderveen MA, Castelijns JA, Scheltens P, Lycklama à Nijeholt GJ, et al.

Measuring myelin repair and axonal loss with diffusion tensor imaging

Author(s): Fox RJ, Cronin T, Lin J, Wang X, Sakaie K, et al.

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

Author(s): Fu L, Matthews PM, De Stefano N, Worsley KJ, Narayanan S, et al.

T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis

Author(s): Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, et al.

Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features

Author(s): Tubridy N, Coles AJ, Molyneux P, Compston DA, Barkhof F, et al.

Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials

Author(s): Barkhof F, Held U, Simon JH, Daumer M, Fazekas F, et al.

Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis

Author(s): Bellmann-Strobl J, Wuerfel J, Aktas O, Dörr J, Wernecke KD, et al.